Erlotinib Accord
Active substance: erlotinib
erlotinib
Centralised EU authorisationActive
Marketing holder: Accord Healthcare S.L.U.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 30 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-626f-76f7-8600-fb09a3a48015,01a1208c-a68f-7cd0-b6af-f37da7ef915d,01a1208d-0122-77e8-bd41-1d23da3e09ab,01a1208d-05a4-7d1b-9fb9-511eeb14e392,01a1208d-66bc-7acb-8c25-0e9036be72db;count=30 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/005071
- Registration status
- Active
- ATC code
- L01XE03
Sources
- product · EMA · EMEA/H/C/005071 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005071 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005071 · Verified 2026-10-09